Cg Oncology Inc [CGON] stock is trading at $34.10, up 0.59%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CGON shares have gain 5.77% over the last week, with a monthly amount drifted -5.78%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cg Oncology Inc [NASDAQ: CGON] stock has seen the most recent analyst activity on October 24, 2024, when UBS initiated its Buy rating and assigned the stock a price target of $60. Previously, RBC Capital Mkts started tracking the stock with Outperform rating on September 23, 2024, and set its price target to $66. On August 28, 2024, ROTH MKM initiated with a Buy rating and assigned a price target of $65 on the stock. BofA Securities started tracking the stock assigning a Buy rating and suggested a price target of $65 on June 28, 2024. Morgan Stanley initiated its recommendation with a Overweight and recommended $55 as its price target on February 20, 2024. Goldman started tracking with a Neutral rating for this stock on February 20, 2024, and assigned it a price target of $42. In a note dated February 20, 2024, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $75 on this stock.
Cg Oncology Inc [CGON] stock has fluctuated between $25.77 and $50.23 over the past year. Currently, Wall Street analysts expect the stock to reach $62.33 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $34.10 at the most recent close of the market. An investor can expect a potential return of 82.79% based on the average CGON price forecast.
Analyzing the CGON fundamentals
Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at -139.69%, Pretax Profit Margin comes in at -105.78%, and Net Profit Margin reading is -105.78%. To continue investigating profitability, this company’s Return on Assets is posted at -0.13, Equity is -0.16 and Total Capital is -0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 33.74 points at the first support level, and at 33.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 34.64, and for the 2nd resistance point, it is at 35.18.
Ratios To Look Out For
For context, Cg Oncology Inc’s Current Ratio is 35.32. Further, the Quick Ratio stands at 35.32, while the Cash Ratio is 2.78. Considering the valuation of this stock, the price to sales ratio is 3411.43, the price to book ratio is 4.29.
Transactions by insiders
Recent insider trading involved Song Hong Fang, Director, that happened on Aug 29 ’24 when 0.65 million shares were sold. Director, Unique Diamond Investments Ltd completed a deal on Aug 29 ’24 to buy 0.42 million shares. Meanwhile, Director Charming Jade Ltd bought 0.23 million shares on Aug 29 ’24.
